Updated April 12, 2026Expert Reviewed

Best HSA/FSA-Eligible Semaglutide Providers — Ranked & Reviewed

Use your pre-tax Health Savings Account or Flexible Spending Account dollars on semaglutide. These providers accept HSA/FSA cards directly or supply itemized receipts for reimbursement.

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

Methodology & sources

Providers in this variant are scored against our published six-factor rubric[1], then filtered to match the specific criteria shown in the page title.

Published Phase 3 efficacy for semaglutide 2.4 mg (~14.9% mean weight loss over 68 weeks) comes from the STEP 1 trial[2]. The SURMOUNT-5 head-to-head published in 2025 directly compared tirzepatide and semaglutide[3].

Compounded and brand-name GLP-1s are generally FSA/HSA eligible with a valid prescription under IRS Publication 502[4]. State Medicaid coverage of anti-obesity medications varies widely[5][6].

No providers match this variant yet. Check back soon — pricing data is being backfilled.
← See all Semaglutide Providers

Frequently Asked Questions

Sources & methodology — as of April 2026
  1. 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
  2. 2.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
  3. 3.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
  4. 4.IRS Publication 502 — Medical and Dental Expenses (HSA/FSA eligibility)— Internal Revenue Service.
  5. 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
  6. 6.CMS — Medicaid prescription drug coverage policy (state-by-state)— Centers for Medicare & Medicaid Services.